Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-022799
Filing Date
2022-08-15
Accepted
2022-08-15 14:58:58
Documents
39
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 460367
2 ex10-2.htm EX-10.2 263565
3 ex31-1.htm EX-31.1 17471
4 ex31-2.htm EX-31.2 17433
5 ex32-1.htm EX-32.1 8018
6 form10-q_1.jpg GRAPHIC 2916
  Complete submission text file 0001493152-22-022799.txt   2324968

Data Files

Seq Description Document Type Size
7 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vapa-20220630.xsd EX-101.SCH 16854
8 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vapa-20220630_cal.xml EX-101.CAL 29410
9 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vapa-20220630_def.xml EX-101.DEF 43272
10 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vapa-20220630_lab.xml EX-101.LAB 163649
11 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vapa-20220630_pre.xml EX-101.PRE 112552
33 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 181669
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
CQENS Technologies Inc. (Filer) CIK: 0001479915 (see all company filings)

EIN.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55470 | Film No.: 221165039
SIC: 2834 Pharmaceutical Preparations